FDC has informed that the Company has been granted ANDA approval by United States Food and Drug Administration (US FDA), for Dorzolamide and Timolol Ophthalmic Solution USP 22.3mg/6.83mg per ml, a generic version of Cosopt of Oak Pharmaceuticals Inc.
The above information is a part of company’s filings submitted to BSE.